Pars plana vitrectomy with and without triamcinolone acetonide assistance in pseudophakic retinal detachment complicated with proliferative vitreoretinopathy

被引:11
作者
Acar, Nur [1 ]
Kapran, Ziya [1 ]
Altan, Tugrul [1 ]
Unver, Yaprak Banu [1 ]
Pasaoglu, Ercan [1 ]
机构
[1] Beyoglu Eye Res & Training Hosp, Istanbul, Turkey
关键词
pars plana vitrectomy; proliferative vitreoretinopathy; pseudophakic retinal detachment; triamcinolone acetonide; triamcinolone acetonide-assisted pars plana vitrectomy; CONTROLLED CLINICAL-TRIAL; INTRAVITREAL TRIAMCINOLONE; SILICONE OIL; FOLLOW-UP; EYES; VISUALIZATION; TOXICITY; BENEFITS; SURGERY; SAFETY;
D O I
10.1007/s10384-010-0807-z
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
To evaluate the anatomical and functional outcomes of pars plana vitrectomy (PPV) in pseudophakic retinal detachment (RD) complicated with proliferative vitreoretinopathy (PVR) without previous scleral buckling (SB) or vitrectomy, both with and without triamcinolone acetonide (TA) assistance. In this retrospective, interventional, comparative case series, 72 pseudophakic eyes with RD with PVR grade C1 or greater underwent PPV either with (group 1, n = 40) or without (group 2, n = 32) TA assistance. Eyes with a minimum of 6 months of follow-up were evaluated. Main outcome measures were reattachment, redetachment, complication rate, and changes in visual acuity (VA). The mean follow-up period was 14.57 +/- 8.55 months. Single-surgery and final reattachment rates were 87.50% and 95% in group 1, and 78.12 % and 96.87% in group 2, (P = 0.349, P = 1.000). Redetachment rates were 12.50% in group 1 and 21.87% group 2 (P = 0.349). In both groups the mean VA increased significantly in postoperative week 1 and in all control visits (P < 0.001) with no difference in complication rate (P > 0.05). In this study PPV with TA assistance resulted in a lower, albeit statistically insignificant, redetachment rate in the treatment of RD complicated with PVR compared to PPV without TA assistance in eyes without previous SB or PPV. Visual acuity improved in 72% of eyes in both groups. Intraoperative and postoperative complication rates were also similar.
引用
收藏
页码:331 / 337
页数:7
相关论文
共 25 条
[1]  
Abrams G.W., 1997, ARCH OPHTHALMOL-CHIC, V115, P407
[2]   Vitrectomy with silicone oil or long-acting gas in eyes with severe proliferative vitreoretinopathy: Results of additional and long-term follow-up - Silicone study report 11 [J].
Abrams, GW ;
Azen, SP ;
McCuen, BW ;
Flynn, HW ;
Lai, MY ;
Ryan, SJ .
ARCHIVES OF OPHTHALMOLOGY, 1997, 115 (03) :335-344
[3]  
[Anonymous], 1992, ARCH OPHTHALMOL, V110, P780
[4]  
[Anonymous], 1983, OPHTHALMOLOGY, V90, P121
[5]   Safety profile of intravitreal triamcinolone acetonide [J].
Baath, J. ;
Ells, A. L. ;
Crichton, A. ;
Kherani, A. ;
Williams, R. G. .
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2007, 23 (03) :304-310
[6]  
BARR CC, 1993, OPHTHALMOLOGY, V100, P1629
[7]  
Beck RW, 2009, ARCH OPHTHALMOL-CHIC, V127, P245, DOI 10.1001/archophthalmol.2008.610
[8]   CLINICAL EVALUATION OF THE SAFETY AND EFFICACY OF PRESERVATIVE-FREE TRIAMCINOLONE (TRIESENCE® [TRIAMCINOLONE ACETONIDE INJECTABLE SUSPENSION] 40 MG/ML) FOR VISUALIZATION DURING PARS PLANA VITRECTOMY [J].
Dyer, David ;
Callanan, David ;
Bochow, Thomas ;
Abraham, Prema ;
Lambert, Michael ;
Lee, S. Young ;
Schneiderman, Todd ;
Potts, Susan L. ;
Walker, Thomas M. .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2009, 29 (01) :38-45
[9]   Possible benefits of triamcinolone-assisted pars plana vitrectomy for retinal diseases [J].
Enaida, H ;
Hata, Y ;
Ueno, A ;
Nakamura, T ;
Hisatomi, T ;
Miyazaki, M ;
Fujisawa, K ;
Sakamoto, T ;
Ishibashi, T .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2003, 23 (06) :764-770
[10]   Submacular deposition of triamcinolone acetonide after triamcinolone-assisted vitrectomy [J].
Enaida, H ;
Sakamoto, T ;
Ueno, A ;
Nakamura, T ;
Noda, Y ;
Maruoka, K ;
Ishibashi, T .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2003, 135 (02) :243-246